![](https://investorshub.advfn.com/uicon/178446.png?cb=1467873950)
Thursday, July 14, 2022 8:50:53 AM
https://www.accesswire.com/708534/halberds-antibody-effective-against-all-4-sars-cov-2-mutations-including-omicron
Boosts Effectiveness of Commercial Covid Antibodies by 45%
JACKSON CENTER, PA / ACCESSWIRE / July 14, 2022 / Halberd Corporation (OTC PINK:HALB) researchers developed, with appropriate protocols, a SARS-CoV-2 antibody effective against all four Covid-19 mutations currently in circulation, including Omicron. When Halberd's antibody was combined with a leading commercially available Covid-19 antibody in an antibody cocktail, effectiveness of the commercial antibody was increased from 65% to 94%. This could lead to a treatment that is widely effective against existing and future mutations of SARS-CoV-2.
Dr. Mitchell S. Felder, Halberd's Chief Technology Officer and a board-certified attending neurologist stated, "Our university in-vitro lab testing showed that the HALB monoclonal antibody is able to neutralize the original Covid strain, the Covid Delta strain and the Omicron strain. We are not aware of any other monoclonal antibody which is able to neutralize the Covid Omicron strain with this level of efficiency. Our proprietary monoclonal antibody has the potential to substantially increase the efficacy of the commercially available intravenous monoclonal antibody infusion treatment for Covid. Given the consistency at which our antibody has worked across current multiple mutations, Halberd's monoclonal antibody is more likely to be effective in treating current and/or future variants than commercially available treatments. Since we know that Covid-19 is quite susceptible to mutating, Covid is almost impossible to eradicate unless the treatment is effective against future variants."
William A. Hartman, Chairman, President & CEO of Halberd Corporation, added, "We are currently in discussions with our patent attorney to determine the breadth of intellectual property available to Halberd. We expect the outstanding results achieved in our laboratory testing will spawn several patents and garner enhanced interest beyond our recent preliminary industry discussions."
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM